Viet Phap Sponsors a series of Continuing Medical Education in Nephrology and Kidney Transplant

Last mid-October, Viet Phap was pleased to sponsor a Continuous Medical Education (CME) series by two world-leading professors in the field of nephrology and kidney transplantation from Grenoble Medical University Hospital – France, was held at three major hospitals, namely Cho Ray Hospital, Hue Central Hospital and Hanoi Medical University Hospital.

The opening session was the Scientific Activities Program with the theme: “Immunosuppression Used in Kidney Transplant: Challenges and Opportunities”, which took place on the morning of October 16, 2017 at Cho Ray Hospital. The program attracted the attention and participation of dozens of urological surgeons from many hospitals in Ho Chi Minh City such as Cho Ray, Thong Nhat, Binh Dan, 115, Xuyen A…

Prof. Lionel Rostaing and Prof. Paolo Malvezzi take pictures with practitioners at Cho Ray Hospital

Following that, the CME on Nephrology and Kidney Transplantation at Hue Central Hospital took place in two days October 17-18, 2017 for their doctors, surgeons and on October 19, 2017 at Medical University Hospital for doctors at some big hospitals in North Vietnam such as Bach Mai, Viet Duc, Vinmec …

Two professors take pictures with practitioners at Hue Central Hospital

Through the program, Professors Lionel Rostaing and Paolo Malvezzi have provided the latest knowledge on immunosuppressive therapies for induction and maintenance use in kidney transplantation, treatment of rejection, and management of post-transplant infections …


GS. Lionel Rostaing is giving a lecture at Hue Central Hospital

In particular, the two professors shared their experiences of using biologic Grafalon safely and effectively at Grenoble Medical University Hospital. This is a product of Neovii company – Germany, containing polyclonal anti-lymphocyte globulin [rabbit] (rATG), strongly inhibiting the activity of lymphocyte immune cells, especially T cells, thereby allowing kidney transplantation to take place more safely and preventing the risk of rejection later while limiting the use of long-term corticosteroids. Although Grafalon has been widely used in Europe for a long time, it is still quite new in Vietnam. Therefore, many questions regarding the choice of Grafalon over other immunosuppressive therapies, dosage, and how to use this preparation in actual clinical cases were raised by practitioners in all three regions for discussion.

The professors said that Grafalon was used at Grenoble Hospital in the induction regimen for most kidney transplant patients, especially those at high risk of rejection because rATG was more effective than hATG (equine ATG) and the dosage was flexible. The two professors also emphasized that we should adjust the dosage and infusion time of Grafalon appropriately to limit the risk of post-transplant infections and complications. The infusion time should be at least 4 hours, then can be increased to 6-12 hours and even up to 24 hours based on patient response.

Pictures of CME at Hue Central Hospital

Vietnam has more than 2,400 patients being reborn thanks to the success of organ transplants, of which 2300 cases are kidney up to the end of May 2017. Of which, more than 2,300 cases are kidney transplants. Although the organ transplant industry in general and kidney transplant in particular in Vietnam has achieved a lot of medical achievements in the past 25 years since the first transplant in 1992, it has not yet caught up with this field in developed countries. Therefore, this series of CME is a valuable opportunity for doctors and experts in Vietnam to exchange and learn clinical experiences with leading experts in the world, especially in kidney transplants

Viet Phap is very honored to participate in contributing to the successful continuing medical education.